August 8, 2020         
nTIDE July 2020 Jobs Report: July Numbers Raise Red Flag for Americans with Disabilities   •   Sanctuary Taps Cinedigm and VIZIO to Bring Its Yoga Meditation Service to People at Home   •   United Methodists to Host "Dismantling Racism" Town Hall Discussions   •   Government of Canada COVID-19 Update for Indigenous Peoples and communities   •   Gardner Capital Debuts Senior Living Community and Food Pantry in El Caro Senior Apartments in Phoenix   •   Illinois officials find Kanye West does not have enough signatures to be a candidate for President in the general election in hi   •   Cola Wealth Advisors Honors Major Rick "Guns" Garin   •   Splenda® Brand Sweeteners Supports 10-Year-Old Philadelphia Entrepreneur's Lemonade Stand Business   •   Ready to Go on Day One: Indiana Gateway Digital Academy Students Already Equipped for Success   •   Mycovia Pharmaceuticals CEO Patrick Jordan Named 2020 Life Sciences CEO of the Year by Triangle Business Journal   •   #iVoted Initiative to Break All Records with Election Night Virtual Concerts   •   NASA Astronaut Aboard Space Station to Answer Girl Scouts' Questions   •   Knights of Columbus Recognizes Family of the Year, Local Councils for Outstanding Contributions   •   AtriCure Announces Angie Wirick as Chief Financial Officer   •   Genentech Provides Update on Phase III Study of Tecentriq in Combination With Paclitaxel for People With Metastatic Triple-Negat   •   Housing Rights Advocates to Burbank City Council: Stop Wasting Taxpayer Money   •   Ford Fund and 1863 Ventures Announce Next HI-HERImpact Pitch Competition   •   Christopher & Dana Reeve Foundation August Events   •   Class Is in Session for Hearthstone® Players—New Expansion Scholomance Academy™ Now Live!   •   2020 Women Tech Awards Finalists Named
Bookmark and Share

Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner

Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner

Appointment of Seasoned Biopharma Veteran Strengthens Growing Life Sciences Investment Firm

PR Newswire

WALTHAM, Mass., July 16, 2020 /PRNewswire/ -- Agent Capital, a majority woman-owned international life sciences investment firm supporting disruptive healthcare companies, announced the appointment of industry veteran Jacopo Leonardi as Partner. Jacopo is a proven global biopharmaceutical executive with a 25-year track record of creating sustainable growth for new ventures and underperforming franchises. The addition of Jacopo enhances Agent Capital's well-established reputation for value creation, strategic acumen, and access to premier life sciences industry talent and deals.

Jacopo's deep expertise in global commercial operations and launch excellence across multiple therapeutic areas including orphan and rare diseases, immunology, and neurology aligns with Agent Capital's investment focus on subsectors that generate the highest potential returns. In addition to his experience managing a range of functions including R&D, Medical Affairs, Manufacturing, and Quality, Jacopo brings his strong reputation as a leader and mentor known for building inspired and inclusive teams, recognizing talent, and fostering career growth, for which he was celebrated by the Healthcare Businesswomen's Association (HBA) as their 2016 Honorable Mentor of the Year.

"We are excited to have Jacopo join our team as we enter our next phase of growth and investment," said Dr. Geeta Vemuri, Managing Partner and Founder of Agent Capital. "Throughout his career Jacopo has embodied our investment philosophy – diverse management teams lead to superior investment returns and a greater ability for portfolio companies to develop the next generation of healthcare innovators and innovations. I look forward to working again with Jac to support our current and future partners on their path to success."

Founded in 2016, Agent Capital's investment strategy and diverse team have earned them access to a vast pipeline of high-value potential deals and a syndicate network of investment partners that enables them to drive portfolio growth and exit. Agent Capital's first fund (Fund I), initially focused on novel, differentiated therapeutics and treatments that address unmet patient needs, has invested in 14 healthcare companies – four of which have successfully gone public. Prior to Agent Capital the team invested for Baxter and Baxalta as corporate venture capitalists from 2012 to 2016 and had five significant trade sales in their prior portfolio. Agent Capital is poised for growth due to their track record of accelerating value creation and ability to provide industry-leading strategic thinking, R&D and commercial stewardship experience, access to top talent, and coaching and mentorship for management teams.

"I am honored to have the opportunity to work with Geeta and the Agent Capital team to continue to pursue my career-long passion of cultivating diverse teams and shepherding promising healthcare solutions from the spark of innovation to commercially successful products that make an impact on patients' lives," said Jacopo Leonardi, Partner with Agent Capital. "As an executive and entrepreneur, I am thrilled to be able to apply my experience developing and maximizing the potential of organizations and individuals to the next generation of healthcare innovation."

Prior to Agent Capital, Jacopo served on boards and in executive leadership across multiple companies in concierge health and specialty pharmacy. As an Operating Partner at The Vistria Group, Jacopo was part of a team that acquired and helped accelerate the growth of AIS Healthcare, and he currently serves on the company's board of directors. Earlier in his career, Jacopo was Executive Vice President and President of Immunology for Baxalta and has spent 20 years in key development and global leadership roles in general management, marketing, sales, and R&D at Eli Lilly, Johnson & Johnson, Baxter, and Baxalta.


Agent Capital is an international life sciences investment firm that supports disruptive healthcare companies focusing on novel, differentiated therapeutics and treatments that address unmet patient needs. Agent Capital aligns with scientists, entrepreneurs, and other investors to develop the next generation of healthcare innovations, leverages their industry expertise and successful track record to source premier deals, accelerate value, and drive successful exits. Their first fund invested in 14 portfolio companies, of which four have gone public. Agent Capital has offices in Boston, Massachusetts.


Cision View original content:

SOURCE Agent Capital

Back to top
| Back to home page

White House Live Stream
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News